Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2006 | 03-2006 | 09-2005 | 06-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 2 | N/A | N/A | N/A |
| Marketable Securities | 1,386 | N/A | N/A | N/A |
| Receivables | 6 | N/A | N/A | N/A |
| Other current assets | 1 | 0 | 0 | 0 |
| TOTAL | $1,928 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 392 | N/A | N/A | N/A |
| Other Non-Current Assets | 104 | 0 | 0 | 0 |
| TOTAL | $496 | $N/A | $N/A | $N/A |
| Total Assets | $2,424 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 501 | 0 | 0 | 0 |
| Accrued Expenses | 42 | N/A | N/A | N/A |
| TOTAL | $664 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 50 | N/A | N/A | N/A |
| Deferred Revenues | 121 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 312 | 0 | 0 | 0 |
| TOTAL | $362 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,026 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 328 | N/A | N/A | N/A |
| Common Shares | 33 | N/A | N/A | N/A |
| Retained earnings | -7,899 | N/A | N/A | N/A |
| Other shareholders' equity | 5,294 | 0 | 0 | 0 |
| TOTAL | $1,398 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $2,424 | $0 | $0 | $0 |